ASCO Rx for high drug costs: doctors and patients need to talk.

نویسنده

  • Joanne Nicholas
چکیده

A special task force of the American Society of Clinical Oncology (ASCO) recently issued a Guidance Statement on the Cost of Care , which advises oncologists to speak with their patients about the cost of treatment. While urging ASCO to also address underlying economic factors that drive costs, the guidance focused on issues at the practice level. " The task force tried to address the rising costs of cancer care and how it affects the practicing of quality medicine and the well-being of the patient, " said chair Medical School in Boston. The statement highlighted a recognized problem: Doctors and patients have difficulty broaching fi nancial topics in the context of an offi ce visit. But it did not offer specifi c suggestions on how to effect changes necessary for both sides to communicate. In fact, several large, entrenched roadblocks need to be overcome before this kind of communication can take place, according to oncologists and patient advocates. Few dispute the importance of such discussions or the effect that costs can have on patient care. " Without a conversation about cost, there is no way for doctors to know how many patients are being forced to make decisions about treatment while weighing other demands such as supporting their families [and] children to be educated , " Schnipper said.gist and end-of-life specialist at the Mayo Clinic in Rochester, Minn., agreed: " The reality of it is, a prescription you don't take because you can't afford to has a zero response rate. If an aromatase inhibitor costs a patient $300 out of pocket versus $70 for tamoxifen, it is important for an oncologist to know if this expense will affect the patient's compliance, " he said. Moynihan is also concerned about prescribing a high-cost treatment without fully describing its risks and benefi ts to a patient near the end of life. " If someone is going to get a very expensive therapy, their doctor needs to explain that it may only change their outcome by 6 weeks, they may have to

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

The drug cost gap and the diagnosis-prescription connection.

Although the rise in pharmacy benefit costs continues to outpace overall medical cost inflation, the gap is narrowing. Employers can improve cost and employee wellness even further with an innovative technique for drug therapy compliance called the Diagnosis-Prescription (Dx-Rx) approach. This article reports results from a 2007 national employer survey on pharmacy benefits and describes how th...

متن کامل

All It Takes for Corruption in Health Systems to Triumph, Is Good People Who Do Nothing; Comment on “We Need to Talk About Corruption in Health Systems”

Numerous investigations demonstrate that the problem of corruption in the health sector is enormous and has grave negative consequences for patients. Nevertheless, the problem of corruption in health systems is far from eminent in the international health policy debate. Hutchinson, Balabanova, and McKee have identifed in their Editorial five reasons why the health policy community has been relu...

متن کامل

Nonparametric Spectral-Spatial Anomaly Detection

Due to abundant spectral information contained in the hyperspectral images, they are suitable data for anomalous targets detection. The use of spatial features in addition to spectral ones can improve the anomaly detection performance. An anomaly detector, called nonparametric spectral-spatial detector (NSSD), is proposed in this work which utilizes the benefits of spatial features and local st...

متن کامل

High Stakes Require More Than Just Talk: What to Do About Corruption in Health Systems; Comment on “We Need to Talk About Corruption in Health Systems”

Reluctance to talk about corruption is an important barrier to action. Yet the stakes of not addressing corruption in the health sector are higher than ever. Corruption includes wrongdoing by individuals, but it is also a problem of weak institutions captured by political interests, and underfunded, unreliable administrative systems and healthcare delivery models. We ur...

متن کامل

Polypharmacy vs. Deprescribing

Usually, the elderly and patients with chronic diseases visit several doctors and are supposed to take multiple medications. The multiplicity of medications is called polypharmacy and it may cause side effects, drug interactions and other helth issues for the patient, and it might go as far as the patient might need to go to the hospital and be admitted in ICU, or even further and be the cause ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Journal of the National Cancer Institute

دوره 101 21  شماره 

صفحات  -

تاریخ انتشار 2009